Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-423-6 | CAS number: 54982-83-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Bioaccumulation: aquatic / sediment
Administrative data
Link to relevant study record(s)
Description of key information
The BCF is 156 l/kg based on read across from Verdox, which is tested in an OECD TG 305 (Klimisch 1).
Key value for chemical safety assessment
- BCF (aquatic species):
- 156 L/kg ww
Additional information
The BCF of Zenolide is derived by using read across from Verdox which documentation is presented below. This section starts however with the executive summary of the BCF of Verdox followed by the conclusion on Zenolide.
Bioaccumulation of Verdox
The bioconcentration of the test substance in rainbow trout (Oncorhynchus mykiss) was determined in a GLP-compliant OECD guideline 305 study. In this flow-through test, groups of 85 fish were exposed for a 33-day uptake phase to nominal test concentrations of 0, 1.7 and 17 µg/L of the test substance followed by a 10 day depuration phase. Steady-state concentrations of 14C-labelled test substance were achieved in the tissues of rainbow trout (Oncorhynchus mykiss) after 33 days. The mean measured water concentrations based on total radioactivity were 2.3 and 29 μg/L. Steady-state BCF values for the 2.3 µg/L test concentration, based on total radioactivity of the test substance concentrations were 65, 335 and 179 in edible, non-edible and whole fish tissue, respectively. Steady-state BCF values for the 29 µg/L test concentration, based on total radioactivity of the test substance concentrations were 66, 402 and 203 in edible, non-edible and whole fish tissue, respectively. The test substance depurated quickly in fish tissue and ranged from 0.5 to 7 % of Day 33 steady-state values by Day 10 of depuration. Kinetic BCFK values derived by nonlinear regression for the 2.3 µg/L treatment group were 65, 312 and 167 for edible, non-edible and whole fish tissue, respectively. The time to reach 90 % steady state based on kinetics was 13.5, 5.3 and 6.6 days and time to reach 50 % clearance was 4.06, 1.61 and 2.00 days for edible, non-edible and whole fish tissue, respectively. The BCF whole fish of 203 will be converted to a lipid content of 5%, resulting in a BCF value of 156, which will be used for the CSA.
Bioaccumulation of Zenolide in an integrated testing strategy
Based solely on Zenolide’s characteristic the substance is not bioaccumulating:
1) It has a log Kow 3.65;
2) The substance is an ester which metabolises into Ethylene glycol and Dodecanedioic-acid , which are both non-bioaccumulating based on: a) low log Kow (-1.67 and 3.17, respectively); b) both being consumed in the Krebs-cycle (a glycol and a fatty acid); and 3) both are readily biodegradable.
3) When calculating the BCF of Zenolide with the Veith relationship, the BCF is 254 l/kg ww (< 500). The Veith relationship is incorporated in EUSES and is applicable for substances with a log Kow up to 6: log BCF = 0.85 log Kow - 0.70.
4) When using the BCFBAF calculation, which includes metabolism, the BCF is estimated to be 283 and the DT50 is determined to be 3.24 minutes.
5) The BCFBAF calculation aligns with the BCF of the analogue Verdox, which has a BCF of 156 which is the key value also used for Zenolide and the read across justification is presented below.
Overall the BCF information presented support each other. Therefore, the information is sufficient for hazard assessment, C&L, PBT and risk characterization.
Bioaccumulation of Zenolide (CAS #54982-83-1) using read across from data available from Verdox (CAS #20298-69-5).
Introduction and hypothesis for the analogue approach
Zenolide is a cyclic aliphatic double ester. For this substance no experimental bioaccumulation test (OECD TG 305) is available. In view of its log Kow of 3.65, further BCF information is relevant because this value of 3.65 is higher than the cut off of 3 presented in Annex IX and therefore further information is needed. In addition to other information indicating absence of bioaccumulation such as QSAR information and ready biodegradability also information from an experimental BCF is used from the related analogue Verdox. In accordance with Article 13 of REACH, lacking information can be generated by i.e. applying alternative methods such as in vitro tests, QSARs, grouping and read-across. For assessing the bioaccumulation potential of Zenolide the analogue approach is selected because for the analogue Verdox in vivo experimental bioaccumulation information is available, which can be used for read across.
Hypothesis: Zenolide has a similar or lower bioaccumulation potential compared to Verdox.
Available information: For Verdox the BCF is 156 l/kg (including 5% lipid normalisation), based on an OECD TG 305 test (GLP and Klimisch 1).
Target chemical and source chemical
The information on Zenolide and Verdox supporting the read across are presented in the Data matrix.
Purity / Impurities
Zenolide is a mono-constituent with a high purity> 95% and therefore the impurities are not expected to influence the results.
Analogue approach justification
According to Annex XI 1.5 read across can be used to replace testing when the similarity can be based on a common backbone and a common functional group. When using read across the result derived should be applicable for C&L and/or risk assessment and it should be presented with adequate and reliable documentation, which is presented below.
Analogue justification: For Zenolide the substance Verdox is selected because of the structural similarity and for Verdox an experimental BCF information is available.
Structural similarities and differences: Zenolide has a Cyclic C13 backbone bridged with an Ethylene glycol group, while Verdox has a C11 backbone: a cyclohexyl ring to which a tert-butyl group is attached. Zenolide has a double ester within the ring while Verdox has a single ester outside its ring.
Bioavailability: Both substances are esters and present similar bioavailability based on their physico-chemical properties. Zenolide has slightly higher water solubility and a lower log Kow due to the double ester. The physico-chemical properties of both substances are in the range of being well bioavailable.
Metabolism: Zenolide and Verdox are both esters and therefore the first metabolisation step is the same and the basis for this read across. These esters will be readily cleaved by carboxyl-esterases (see metabolic scheme below) (Wheelock et al. 2008). It has been shown that Zenolide is instantaneously degraded in rat blood by carboxylesterases. As in fish tissue carboxyl esterases are present, Zenolide will also be metabolised in Ethylene Glycol and Dodecanedioic acid, while Verdox will be cleaved into its respective alcohol and acetic acid.
Fig. 1. The anticipated metabolism of Zenolide and Verdox, respectively.
Uncertainty of the prediction: The BCF value derived from Verdox is considered conservative for Zenolide for three reasons. a) The metabolites of Zenolide are expected to be fully metabolised presenting absence of bioaccumulation, while the first metabolite of Verdox being its alcohol may be a bit more resistant to further metabolization. b) Zenolide is readily biodegradable while Verdox degrades up to 43%. c) QSAR-prediction using BCFBAF shows that Zenolide is expected to have a slightly lower BCF compared to Verdox.
Table 1: Comparison bioaccumulation and biodegradation
Substance |
BCF experimental |
BCF – EPISUITE |
DT50 |
Zenolide CAS #54982-83-1 |
No data |
283 |
0.05 days (1.3 hours) |
Verdox CAS #20298-69-5 |
156 (lipid corrected) |
384 |
0.44 days (10.6 hours) |
Data matrix
The relevant information on physico-chemical properties and other environmental fate properties are presented in the Data Matrix below.
Conclusions on bioaccumulation
For Zenolide no experimental BCF is available. For the analogue Verdox such information is present, which can be used for read across. When using read across the result derived should be applicable for C&L and/or risk assessment and be presented with adequate and reliable documentation. This documentation is presented in the current document. Verdox has an experimental steady state BCF value of 156 l/kg (5% lipid normalised, OECD TG 305 test, Kl. 1), which can be directly applied to Zenolide in view of structure, bioavailability and metabolic features.
Final conclusion: Zenolide is not bioaccumulating and has a BCF of 156 l/kg.
Data matrix to support the read across to Zenolide from Verdox on bioaccumulation
Common names |
Zenolide |
Verdox |
Chemical structures |
||
CAS No. |
54982-83-1 |
20298-69-5 |
EC no |
259-423-6 |
243-718-1 |
REACH registered |
Registered |
Registered |
Empirical formula |
C14H24O4 |
C12H22O2 |
Molecular weight |
256 |
198 |
Physico-chemical properties |
|
|
Physical state |
liquid |
Liquid at 30°C |
Water solubility, mg/L |
75 |
10 |
Log Kow |
3.65 |
4.75 |
Environmental fate |
|
|
Biodegradation |
Ready biodegradable |
Not readily biodegradable (43% degradation) |
BCF (L/kg) |
156 Read across from Verdox |
156 (OECD TG 305, Kl. 1) |
References:
Wheelock, C.E., Philips, B.M., Anderson, B.S., Miller, J.L., Miller, M.J., and Hammock, B.D., 2008, Application of carboxylesterase activity in environmental monitoring and toxicity identification evaluations, (TIEs), in Reviews of Environmental Contamination and Toxicology, ed. Whitacre, 117-178, D.M., Springer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.